These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33430227)

  • 1. Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics.
    Alemany-Cosme E; Sáez-González E; Moret I; Mateos B; Iborra M; Nos P; Sandoval J; Beltrán B
    Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33430227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis.
    Haag LM; Siegmund B
    Front Immunol; 2015; 6():489. PubMed ID: 26441993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis.
    Loddo I; Romano C
    Front Immunol; 2015; 6():551. PubMed ID: 26579126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome, Metabolome and Inflammatory Bowel Disease.
    Ahmed I; Roy BC; Khan SA; Septer S; Umar S
    Microorganisms; 2016 Jun; 4(2):. PubMed ID: 27681914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection.
    Buttó LF; Schaubeck M; Haller D
    Front Immunol; 2015; 6():555. PubMed ID: 26635787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dormant Crohn's Disease Reactivated by Clostridioides difficile Infection.
    Hernandez OL; Suarez ZK; Nagi T; Vallejo C; Ferris A
    Cureus; 2023 Apr; 15(4):e37062. PubMed ID: 37153283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut.
    Buttó LF; Haller D
    Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF; Bernardazzi C; Castro F; de Souza HSP
    World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea-From an Antioxidant Perspective.
    Li Q; Zheng T; Ding H; Chen J; Li B; Zhang Q; Yang S; Zhang S; Guan W
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.
    Xun Z; Zhang Q; Xu T; Chen N; Chen F
    Front Microbiol; 2018; 9():1136. PubMed ID: 29899737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidative stress in Crohn's disease].
    Moret I; Cerrillo E; Navarro-Puche A; Iborra M; Rausell F; Tortosa L; Beltrán B
    Gastroenterol Hepatol; 2014 Jan; 37(1):28-34. PubMed ID: 23643278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.